Therefore, the goal of this review is to highlight the importance of custom therapeutic strategies for HCC patients, taking into consideration the dynamic nature of the interactions between Il-6 and the tumor microenvironment. This evidence concerns the gene IL6 and hepatocellular carcinoma.